DA-90
Showing 1 - 25 of 9,842
Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))
Recruiting
- Acute Myeloid Leukemia
- A arm (DA-90)
- +3 more
-
New York, New York
- +9 more
Sep 30, 2021
Coronary Artery Disease Trial in Porto Alegre (implant)
Active, not recruiting
- Coronary Artery Disease
- implant
-
Porto Alegre, Rio Grande Do Sul, BrazilUnião Brasileira de Educação e Assistência - Hospital São Lucas
May 7, 2022
Healthcare Resource Utilization in Adult Myelofibrosis Through
Recruiting
- Myelofibrosis
-
La Plata, Buenos Aires, Argentina
- +62 more
Feb 1, 2023
Ulcerative Proctitis Trial in Worldwide (Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure
Recruiting
- Ulcerative Proctitis
- Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator
- +2 more
-
Huntsville, Alabama
- +74 more
Aug 17, 2022
Lung Transplantation, Electric Stimulation, Clinical Trial Trial in Porto Alegre (Neuromuscular electrical stimulation,
Unknown status
- Lung Transplantation
- +2 more
- Neuromuscular electrical stimulation
- Conventional care
-
Porto Alegre, Rio Grande Do Sul, Brazil
- +1 more
Jun 1, 2020
Tracheomalacia Trial in New York (Dynamic Airway CT scan (DA-CT))
Recruiting
- Tracheomalacia
- Dynamic Airway CT scan (DA-CT)
-
New York, New York
- +1 more
Sep 1, 2023
Hair Diseases, Alopecia, Hair Loss Trial in Manaus (DA-OTC-002)
Completed
- Hair Diseases
- +2 more
- DA-OTC-002
-
Manaus, BrazilHospital Oscar Nicolau
Oct 20, 2023
Atopic Dermatitis Trial in Worldwide (Baricitinib, Placebo, Topical corticosteroid)
Active, not recruiting
- Atopic Dermatitis
- Baricitinib
- +2 more
-
Graz, Steiermark, Austria
- +102 more
May 25, 2022
Early Breast Cancer Trial in Worldwide (Trastuzumab and Pertuzumab (FDC SC) and T-DM1)
Recruiting
- Early Breast Cancer
- Trastuzumab and Pertuzumab (FDC SC) and T-DM1
-
Pleven, Bulgaria
- +55 more
Jan 18, 2023
Renal Impairment, Healthy Trial in Gyeonggi-do (DA-8010)
Not yet recruiting
- Renal Impairment
- Healthy
-
Gyeonggi-do, Korea, Republic ofCHA Bundang Medical Center
Apr 2, 2023
GENERATE - Next GENERATion of GynEcological Surgery - Robotic
Not yet recruiting
- GYN Disorders
- Robotic-assisted surgery (da Vinci)
- Non-da Vinci Surgery
- (no location specified)
May 10, 2023
Robotic Surgical Procedure Trial (Lung Anatomic Resection (Da Vinci SP))
Not yet recruiting
- Robotic Surgical Procedure
- Lung Anatomic Resection (Da Vinci SP)
- (no location specified)
Sep 6, 2022
Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive
Recruiting
- Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
- Hot Flashes
- Elinzanetant (BAY3427080)
- Placebo
-
Linz, Oberösterreich, Austria
- +96 more
Jan 10, 2023
Cervical Spinal Cord Injury, Tetraplegia Trial in Saint Louis (Surveys for Research Purposes)
Completed
- Cervical Spinal Cord Injury
- Tetraplegia
- Surveys for Research Purposes
-
Saint Louis, MissouriWashington University School of Medicine
Aug 22, 2022
Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Placebo)
Completed
- Osteoarthritis, Knee
- Osteoarthritis, Hip
- Fasinumab
- Placebo
-
Glendale, Arizona
- +46 more
Dec 2, 2021
Parkinson's Disease Trial in Worldwide (BIA 28-6156 10 mg, BIA 28-6156 60 mg, Placebo)
Recruiting
- Parkinson's Disease
- BIA 28-6156 10 mg
- +2 more
-
Los Angeles, California
- +73 more
Apr 18, 2023
Liver Transplant; Complications Trial in São Paulo (Usual Care + High Target of Mean Arterial Pressure, Usual Care)
Recruiting
- Liver Transplant; Complications
- Usual Care + High Target of Mean Arterial Pressure
- Usual Care
-
São Paulo, SAO Paulo, BrazilHospital Das Clínicas Da Faculdade de Medicina Da Universidade d
Oct 31, 2022
NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (IVA337, Placebo)
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- IVA337
- Placebo
-
Anniston, Alabama
- +352 more
Jan 23, 2023
Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)
Not yet recruiting
- Acute Myeloid Leukemia
- Different induction chemotherapy regimens
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Sep 27, 2023
NSCLC Trial in Worldwide (Sacituzumab Govitecan-hziy (SG), Docetaxel)
Recruiting
- Non-Small Cell Lung Cancer
- Sacituzumab Govitecan-hziy (SG)
- Docetaxel
-
Anchorage, Alaska
- +104 more
Jul 20, 2022
Celiac Disease Trial in Criciúma (Probiotic blend, Placebo)
Recruiting
- Celiac Disease
- Probiotic blend
- Placebo
-
Criciúma, Santa Catarina, BrazilUniversidade do Extremo Sul Catarinense
Dec 2, 2022